Metformina Hexal Ag

Metformin, the active ingredient in Metformina Hexal Ag, is a Biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults. GNH USA supplies Metformina Hexal Ag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Hexal Ag is used to manage disorders of glucose metabolism, primarily in the type 2 diabetes pathway. - Type 2 diabetes mellitus: improves glycaemic control and reduces fasting plasma glucose. - Impaired glucose tolerance: helps delay progression to overt diabetes. - Metabolic syndrome: assists in improving insulin sensitivity and modest weight management.

Metformina Hexal Ag may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Vomiting: occasional emesis, usually early on.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycaemia: when combined with other glucose‑lowering agents. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Skin rash or hypersensitivity: including Stevens‑Johnson syndrome. - Allergic reactions: anaphylaxis or angioedema.

Before initiating Metformina Hexal Ag, several safety considerations should be reviewed. - Renal function: assess creatinine clearance; avoid in severe renal impairment. - Hepatic function: monitor liver enzymes; use cautiously in hepatic disease. - Monitor blood glucose: adjust dose based on glycaemic response. - Alcohol intake: limit consumption to reduce lactic acidosis risk. - Elderly patients: start with lower dose and titrate slowly. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Metformina Hexal Ag can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of renal dysfunction and lactic acidosis. - Cimetidine: may raise metformin plasma concentrations. - Alcohol: potentiates lactic acidosis risk. - Diuretics (loop or thiazide): can impair renal clearance of metformin. - Nifedipine: may enhance metformin’s glucose‑lowering effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Other antidiabetic agents: risk of additive hypoglycaemia. - Thyroid hormones: may affect metabolic rate and glucose control. - Corticosteroids: can increase blood glucose, requiring dose adjustments.